Ouabain-induced hypertension alters the participation of endothelial factors in α-adrenergic responses differently in rat resistance and conductance mesenteric arteries

British Journal of Pharmacology

Volumn 143, Issue 1, 2004, Pages 215-225

  Xavier, Fabiano E ^a,b   Rossoni, Luciana V ^c   Alonso, María J ^a   Balfagón, Gloria ^a   Vassallo, Dalton V ^b   Salaices, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelium; Endothelium derived hyperpolarizing factor; Hypertension; Nitric oxide; Ouabain

Indexed keywords

INDOMETACIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; OUABAIN; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; PROSTANOID; TETRYLAMMONIUM;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CAPACITANCE BLOOD VESSEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANCE BLOOD VESSEL; SUPERIOR MESENTERIC ARTERY; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERTENSION; LOSARTAN; MALE; MESENTERIC ARTERIES; MESENTERIC ARTERY, SUPERIOR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; OUABAIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC, ALPHA; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 4644234381     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705919     Document Type: Article

References (30)

1. - on the endothelial production of prostacyclin. Br. J. Pharmacol., 98, 966-972.
2. BRIONES, A., ALONSO, M.J., HERNANZ, R., TOVAR, S., VILA, E. & SALAICES, M. (2002). Hypertension alters the participation of contractile prostanoids products and superoxide anion in lipopolysaccharide effects on small mesenteric arteries. Life Sci., 71, 1997-2014.
3. CARGNELLI, G., TREVISI, L., DEBETTO, P., LUCIANI, S. & BOVA, S. (2000). Effect of long-term ouabain treatment on contractile responses of rat aortae. J. Cardiovasc. Pharmacol., 35, 538-542.
4. DI FILIPPO, C., FILIPPELLI, A., RINALDI, B., PIEGARI, E., ESPOSITO, F., ROSSI, F. & D'AMICO, M. (2003). Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J. Hypertens., 21, 747-753.
5. DORA, K.A., HINTON, J.M., WALKER, S.D. & GARLAND, C.J. (2000). An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br. J. Pharmacol., 129, 381-387.
6. FELETOU, M. & VANHOUTTE, P.M. (1996). Endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol., 23, 1082-1090.
7. FREITAS, M.R., SCHOTT, C., CORRIU, C., SASSARD, J., STOCLET, J.C. & ANDRIANTSITOHAINA, R. (2003). Heterogeneity of endothelium-dependent vasorelaxation in conductance and resistance arteries from Lyon normotensive and hypertensive rats. J. Hypertens., 21, 1505-1512.
8. HAMLYN, J.M., HAMILTON, B.P. & MANUNTA, P. (1996). Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J. Hypertens., 14, 151-171.
9. +) ATPase associated with essential hypertension. Nature, 300, 650-652.
10. HAYAKAWA, H. & RAIJ, L. (1997). The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension, 29 (Part 2), 235-241.
11. HUANG, B.S., HUANG, X., HARMSEN, E. & LEENEN, F.H.H. (1994). Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension, 23, 1087-1090.
12. HUANG, B.S. & LEENEN, F.H.H. (1999). Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension, 34, 107-112.
13. HUANG, B.S., KUDLAC, M., KUMARATHASAN, R. & LEENEN, F.H.H. (1999). Digoxin prevents ouabain and high salt intake-induced hypertension rats with sinoaortic denervation. Hypertension, 34, 733-738.
14. KIMURA, K., MANUNTA, P., HAMILTON, B.P. & HAMLYN, J.M. (2000). Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens. Res., 23, S67-S76.
15. MANUNTA, P., HAMILTON, B.P. & HAMLYN, J.M. (2001). Structure-activity relationship for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension, 37, 471-477.
16. MANUNTA, P., HAMILTON, B.P., ROGOWSKI, A.C., HAMILTON, B.P. & HAMLYN, J.M. (2000). Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens. Res., 23, S77-S85.
17. MANUNTA, P., ROGOWSKI, A.C., HAMILTON, B.P. & HAMLYN, J.M. (1994). Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J. Hypertens., 12, 549-560.
18. MULVANY, M.J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
19. +-ATPase on the prostacyclin generation of cultured human vascular endothelial cells. Life Sci., 40, 351-357.
20. NAVA, E., NOLL, G. & LÜSCHER, T.F. (1995). Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation, 91, 2310-2313.
21. ROSSONI, L.V., CUNHA, V., FRANÇA, A. & VASSALLO, D.V. (1999). The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J. Cardiovasc. Pharmacol., 34, 887-892.
22. +-ATPase activity and expression in hypertension induced by chronic administration of ouabain. Br. J. Pharmacol., 135, 771-781.
23. ROSSONI, L.V., SALAICES, M., MIGUEL, M., BRIONES, A.M., BARKER, L.A., VASSALLO, D.V. & ALONSO, M.J. (2002b). Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am. J. Physiol., 283, H2110-H2118.
24. TADDEI, S., VIRDIS, A., GHIADONI, L. & SALVETTI, A. (1998). The role of endothelium in human hypertension. Curr. Opin. Nephrol. Hypertens., 7, 203-209.
25. VANHOUTTE, P.M. (1996). Endothelial dysfunction in hypertension. J. Hypertens., 14, S83-S93.
26. VAZIRI, N.D., NI, Z. & OVEISI, F. (1998). Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension, 31, 1248-1254.
27. WARD, S.C., HAMILTON, B.P. & HAMLYN, J.M. (2002). Novel receptors for ouabain: studies in adrenocortical cells and membranes. Hypertension, 39, 536-542.
28. XAVIER, F.E., SALAICES, M., MARQUEZ-RODAS, I., ALONSO, M.J., ROSSONI, L.V., VASSALLO, D.V. & BALFAGON, G. (2004). Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats. J. Hypertens., 22, 949-957.
29. XIE, J., WANG, Y., SUMMER, W.R. & GREENBERG, S.S. (1993). Ouabain enhances basal release of nitric oxide from carotid artery. Am. J. Med. Sci., 305, 157-163.
30. ZHANG, J. & LEHNEN, F.H.H. (2001). AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am. J. Physiol., 280, H1318-H1323.